Senlin Xu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Angiogenesis and VEGF in Cancer 3
- Oncology 16
- Cancer Cells and Metastasis 10
- Co-authors
- Xiu‐Wu Bian (18 shared papers)You‐Hong Cui (13 shared papers)Shi‐Cang Yu (9 shared papers)Yi‐Fang Ping (9 shared papers)Cheng Qian (5 shared papers)Xian-Zong Ye (4 shared papers)Lang Yang (5 shared papers)Xia Zhang (5 shared papers)
- Journals
- Brain Pathology (2 papers)Cancer Letters (2 papers)Cancer Research (2 papers)Hepatology (2 papers)Journal of the American Heart Association (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Senlin Xu
42 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 94
- Cancer Research 610
- Oncology 858
- Genetics 259
- Immunology 456
- Molecular Biology 1.1k
Countries citing papers authored by Senlin Xu
This map shows the geographic impact of Senlin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Senlin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Senlin Xu more than expected).
Fields of papers citing papers by Senlin Xu
This network shows the impact of papers produced by Senlin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Senlin Xu. The network helps show where Senlin Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Senlin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 375 | |
| 2 | 2012 | 261 | |
| 3 | 2014 | 174 | |
| 4 | 2021 | 143 | |
| 5 | 2013 | 107 | |
| 6 | 2014 | 102 | |
| 7 | 2014 | 88 | |
| 8 | 2013 | 75 | |
| 9 | 2011 | 74 | |
| 10 | 2020 | 71 | |
| 11 | 2011 | 68 | |
| 12 | 2016 | 61 | |
| 13 | 2018 | 49 | |
| 14 | Aldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis. | 2015 | 41 |
| 15 | 2014 | 39 | |
| 16 | 2015 | 37 | |
| 17 | 2018 | 35 | |
| 18 | 2019 | 32 | |
| 19 | 2021 | 30 | |
| 20 | Distinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinoma. | 2014 | 20 |
About Senlin Xu
Senlin Xu is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Surgery, having authored 43 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (10 papers), Immune Cell Function and Interaction (4 papers), Immune cells in cancer (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Axon Guidance and Neuronal Signaling (3 papers), MicroRNA in disease regulation (3 papers), Glioma Diagnosis and Treatment (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Cancer Research (610 citations), Oncology (858 citations), Genetics (259 citations), Immunology (456 citations) and Molecular Biology (1.1k citations). Senlin Xu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Xiu‐Wu Bian, You‐Hong Cui, Shi‐Cang Yu, Yi‐Fang Ping, Cheng Qian, Xian-Zong Ye, Lang Yang, Xia Zhang, Hualiang Xiao and Chuan Xu. Their work appears in journals such as Brain Pathology, Cancer Letters, Cancer Research, Hepatology and Journal of the American Heart Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.